Low‐dose rate brachytherapy has become a mainstream treatment option for men
diagnosed with prostate cancer because of excellent long‐term treatment outcomes in low …

Over the past two decades, brachytherapy has played an ever expanding role in the
definitive radiotherapy of prostate cancer. Brachytherapy surpasses external beam …

Abstract Brachytherapy (BT), using low-dose-rate (LDR) permanent seed implantation or
high-dose-rate (HDR) temporary source implantation, is an acceptable treatment option for …

By placing radioactive sources directly into the cancer, brachytherapy allows delivery of a
highly conformal radiation dose to the prostate. Permanent seed brachytherapy is most …

Purpose Patients diagnosed with localized prostate cancer face a myriad of established
treatment options including active surveillance, radical prostatectomy, external beam …

Purpose: Permanent low-dose-rate (LDR-BT) and temporary high-dose-rate (HDR-BT)
brachytherapy are competitive techniques for clinically localized prostate radiotherapy …

Brachytherapy delivers the most conformal high dose radiotherapy possible to the prostate,
using either a low dose rate (LDR) or high dose rate (HDR) technique. It may be used either …

Introduction: Patients with intermediate to high risk disease (prostate specific antigen
(PSA)≥ 10, Gleason score≥ 7, or clinical stage≥ T2b) suffer from poorer long-term …

Purpose To review and analyze the published data on high-dose-rate brachytherapy as
monotherapy in the treatment of prostate cancer. Methods A literature search and a …

Prostate brachytherapy can be used as a monotherapy for low-and intermediate-risk
patients or in combination with external beam radiation therapy (EBRT) as a form of dose …